• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004 - 2014年慢性阻塞性肺疾病相关合并症的定义

Defining COPD-Related Comorbidities, 2004-2014.

作者信息

Martinez Carlos H, Mannino David M, Divo Miguel J

机构信息

Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor.

Departments of Preventive Medicine and Environmental Health, University of Kentucky,College of Medicine and College of Public Health, Lexington.

出版信息

Chronic Obstr Pulm Dis. 2014 May 6;1(1):51-63. doi: 10.15326/jcopdf.1.1.2014.0119.

DOI:10.15326/jcopdf.1.1.2014.0119
PMID:28848811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5560476/
Abstract

Chronic obstructive pulmonary disease (COPD) is a disease of aging in combination with genetic, environmental, and behavioral risk factors. Aging and many of these risk factors are shared with other diseases, and, as a result, it is not surprising that patients with COPD often have coexistent diseases. This review of COPD comorbidities uses a framework in which coexistent diseases are considered important comorbidities if they are more frequent, have more severe consequences, influence the progression and outcomes of COPD, or are clustered together into proposed phenotypes, supplemented by a framework in which certain comorbidities are expected to share specific pathogenic mechanisms. This review explores classic COPD comorbidities such as cardiovascular disease, cachexia and sleep apnea, but also looks at more recently described comorbidities, such as gastroesophageal reflux, osteoporosis and depression/anxiety.

摘要

慢性阻塞性肺疾病(COPD)是一种与遗传、环境和行为风险因素相关的衰老性疾病。衰老以及许多这些风险因素与其他疾病共有,因此,COPD患者常伴有其他共存疾病也就不足为奇了。本综述对COPD合并症采用了一个框架,即如果共存疾病更常见、后果更严重、影响COPD的进展和结局或聚集形成拟表型,则将其视为重要的合并症,并辅以一个框架,其中某些合并症预计具有特定的共同致病机制。本综述探讨了经典的COPD合并症,如心血管疾病、恶病质和睡眠呼吸暂停,也研究了最近描述的合并症,如胃食管反流、骨质疏松症和抑郁/焦虑。

相似文献

1
Defining COPD-Related Comorbidities, 2004-2014.2004 - 2014年慢性阻塞性肺疾病相关合并症的定义
Chronic Obstr Pulm Dis. 2014 May 6;1(1):51-63. doi: 10.15326/jcopdf.1.1.2014.0119.
2
Chronic obstructive pulmonary disease comorbidities.慢性阻塞性肺疾病的合并症
Curr Opin Pulm Med. 2016 Mar;22(2):113-8. doi: 10.1097/MCP.0000000000000241.
3
Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.环境和共病因素对慢性阻塞性肺疾病表型的影响。
Med Clin North Am. 2012 Jul;96(4):713-27. doi: 10.1016/j.mcna.2012.02.007. Epub 2012 Mar 22.
4
Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.慢性阻塞性肺疾病的合并症:一项全国多中心研究项目的结果
Adv Clin Exp Med. 2019 Mar;28(3):319-324. doi: 10.17219/acem/78024.
5
Impact of comorbidities in COPD clinical control criteria. The CLAVE study.COPD 临床控制标准中合并症的影响。CLAVE 研究。
BMC Pulm Med. 2024 Jan 2;24(1):6. doi: 10.1186/s12890-023-02758-0.
6
Comorbidities of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的合并症。
Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S21-8. doi: 10.1097/01.mcp.0000410744.75216.d0.
7
Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病合并症的患病率及负担
Respir Investig. 2016 Nov;54(6):387-396. doi: 10.1016/j.resinv.2016.07.001. Epub 2016 Aug 8.
8
Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review.与慢性阻塞性肺疾病相关的肺外合并症:综述。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 29;19:567-578. doi: 10.2147/COPD.S447739. eCollection 2024.
9
[Risk assessment for sleep apnea syndrome and excessive daytime sleepiness in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者睡眠呼吸暂停综合征及日间过度嗜睡的风险评估]
Acta Med Croatica. 2013 Jun;67(3):219-24.
10
[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].[住院慢性阻塞性肺疾病患者的死亡率和合并症]
Pneumonol Alergol Pol. 2011;79(5):343-6.

引用本文的文献

1
Association between reflux esophagitis and pulmonary function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者反流性食管炎与肺功能之间的关联
J Thorac Dis. 2024 Oct 31;16(10):6545-6552. doi: 10.21037/jtd-24-817. Epub 2024 Oct 14.
2
A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement.改善慢性阻塞性肺疾病和心血管疾病患者结局的研究议程:美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2024 Sep 15;210(6):715-729. doi: 10.1164/rccm.202407-1320ST.
3
Multimorbidities in COPD are Associated With Increased Exacerbations and Health Care Resource Utilization in Real-World Patients from a U.S. Database.慢性阻塞性肺疾病(COPD)的多种合并症与美国数据库中真实世界患者的急性加重增加及医疗资源利用增加相关。
Chronic Obstr Pulm Dis. 2024 Sep 27;11(5):472-481. doi: 10.15326/jcopdf.2024.0515.
4
Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review.慢性阻塞性肺疾病患者合并症的患病率及影响:一项系统评价
Tuberc Respir Dis (Seoul). 2022 Jul;85(3):205-220. doi: 10.4046/trd.2021.0179. Epub 2022 May 27.
5
Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study.在希腊慢性阻塞性肺疾病及合并症患者中,使用埃尔喷吸入器装置递送沙美特罗/氟替卡松固定剂量复方制剂的临床疗效评估:AEOLOS研究
J Pers Med. 2021 Nov 8;11(11):1159. doi: 10.3390/jpm11111159.
6
Pulmonary Dysfunction Augmenting Bacterial Aerosols in Leather Tanneries of Punjab, Pakistan.巴基斯坦旁遮普邦皮革鞣制厂中肺部功能障碍与细菌气溶胶的关系。
Int J Chron Obstruct Pulmon Dis. 2021 Oct 27;16:2925-2937. doi: 10.2147/COPD.S328129. eCollection 2021.
7
Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD Patient.面向多合并症 COPD 患者的常见吸入药物合理处方。
Int J Chron Obstruct Pulmon Dis. 2021 May 11;16:1315-1327. doi: 10.2147/COPD.S298345. eCollection 2021.
8
Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan - Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J).日本综合健康体检人群气流受限的相关因素和合并症-日本慢性阻塞性肺疾病患者流行病学调查(SCOPE-J)。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 23;15:3039-3050. doi: 10.2147/COPD.S272588. eCollection 2020.
9
The Impact of Interprofessional Monitoring and Education on the Usage of Systemic Glucocorticoids in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Medication Use Review.跨专业监测与教育对慢性阻塞性肺疾病急性加重期全身糖皮质激素使用的影响:一项回顾性药物使用审查
Cureus. 2019 Nov 24;11(11):e6224. doi: 10.7759/cureus.6224.
10
Osteoporosis among Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-analysis of Prevalence, Severity, and Therapeutic Outcomes.慢性阻塞性肺疾病患者的骨质疏松症:患病率、严重程度及治疗结果的系统评价和荟萃分析
J Pharm Bioallied Sci. 2019 Oct-Dec;11(4):310-320. doi: 10.4103/jpbs.JPBS_126_19.

本文引用的文献

1
Analysis of comorbid factors that increase the COPD assessment test scores.分析增加 COPD 评估测试评分的合并症因素。
Respir Res. 2014 Feb 6;15(1):13. doi: 10.1186/1465-9921-15-13.
2
Excess risk of chronic physical conditions associated with depression and anxiety.与抑郁和焦虑相关的慢性身体疾病的额外风险。
BMC Psychiatry. 2014 Jan 16;14:10. doi: 10.1186/1471-244X-14-10.
3
Effects of anabolic steroids on chronic obstructive pulmonary disease: a meta-analysis of randomised controlled trials.合成代谢类固醇对慢性阻塞性肺疾病的影响:一项随机对照试验的荟萃分析。
PLoS One. 2014 Jan 10;9(1):e84855. doi: 10.1371/journal.pone.0084855. eCollection 2014.
4
MicroRNAs regulate bone metabolism.微小RNA调控骨代谢。
J Bone Miner Metab. 2014 May;32(3):221-31. doi: 10.1007/s00774-013-0537-7. Epub 2013 Dec 6.
5
An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease.日常步数指数和全身炎症指数可预测慢性阻塞性肺疾病的临床结局。
Ann Am Thorac Soc. 2014 Feb;11(2):149-57. doi: 10.1513/AnnalsATS.201307-243OC.
6
Pharmacokinetics of drugs in cachectic patients: a systematic review.恶液质患者中药物的药代动力学:系统评价。
PLoS One. 2013 Nov 8;8(11):e79603. doi: 10.1371/journal.pone.0079603. eCollection 2013.
7
Increased risk and related factors of depression among patients with COPD: a population-based cohort study.慢性阻塞性肺疾病患者抑郁症的风险增加及相关因素:一项基于人群的队列研究。
BMC Public Health. 2013 Oct 19;13:976. doi: 10.1186/1471-2458-13-976.
8
Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD).脂联素:慢性阻塞性肺疾病(COPD)代谢紊乱的一个有吸引力的标志物。
Nutrients. 2013 Oct 14;5(10):4115-25. doi: 10.3390/nu5104115.
9
Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD.在美国 COPD 队列中,每日步数与血浆 C 反应蛋白和 IL-6 相关。
Chest. 2014 Mar 1;145(3):542-550. doi: 10.1378/chest.13-1052.
10
DNA modifications in atherosclerosis: from the past to the future.动脉粥样硬化中的 DNA 修饰:从过去到未来。
Atherosclerosis. 2013 Oct;230(2):202-9. doi: 10.1016/j.atherosclerosis.2013.07.038. Epub 2013 Jul 27.